Novo Nordisk A/S - Share repurchase programme

July 11, 2011 07:48 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

For release content, please refer to the attachment.

Attachments

Company Announcement no 42 2011

Company Announcement no 42 2011...

Recommended Reading

December 12, 2025 08:57 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss

The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability in the European Union (EU)
Read More
December 09, 2025 08:51 ET | Source: Novo Nordisk A/S

Novo Nordisk has completed its acquisition of Akero Therapeutics

Novo Nordisk and Akero Therapeutics Inc. today announced that Novo Nordisk’s acquisition of Akero, announced on 9 October 2025, has been completed
Read More